APO Research

APO RESEARCH · REPORT

Similar Biological Medicinal Products

Selected research

Industry Research

Similar Biological Medicinal Products Industry Research Report 2026

Market perspective

The global Similar Biological Medicinal Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Similar Biological Medicinal Products is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Similar Biological Medicinal Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Similar Biological Medicinal Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Similar Biological Medicinal Products include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Similar Biological Medicinal Products market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Similar Biological Medicinal Products.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Similar Biological Medicinal Products Market by Company

CITIC Guojian

Changchun High-tech

Innovent Biologics

Saijin Biotechnology

Fuhong Hanlin

Baitai Biology

Biotech

Sandoz

Samsung Bioepies Co., Ltd

Amgen

Celltrion Healthcare

Coherus Biosciences, Inc.

Eli Lilly

Novartis AG

Pfizer Inc

Stada Arzneimittel AG

Teva Pharmaceutical Industries Ltd

Viatris

Similar Biological Medicinal Products Segment by Type

Monoclonal Antibodies

Anti-inflammatory Drugs

Immunomodulator

Recombinant Hormone

Others

Similar Biological Medicinal Products Segment by Application

Oncology

Blood Disorders

Growth Hormone Deficiency

Chronic and Autoimmune Diseases

Others

Similar Biological Medicinal Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Similar Biological Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Similar Biological Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Similar Biological Medicinal Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Similar Biological Medicinal Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Similar Biological Medicinal Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Similar Biological Medicinal Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Similar Biological Medicinal Products Production by Manufacturers (Tons) & (2021-2026) Table 6. Global Similar Biological Medicinal Products Production Market Share by Manufacturers Table 7. Global Similar Biological Medicinal Products Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Similar Biological Medicinal Products Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Similar Biological Medicinal Products Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Similar Biological Medicinal Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Similar Biological Medicinal Products Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Similar Biological Medicinal Products Manufacturers, Product Type & Application Table 13. Global Similar Biological Medicinal Products Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Similar Biological Medicinal Products by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. CITIC Guojian Company Information Table 18. CITIC Guojian Business Overview Table 19. CITIC Guojian Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 20. CITIC Guojian Similar Biological Medicinal Products Product Portfolio Table 21. CITIC Guojian Recent Development Table 22. Changchun High-tech Company Information Table 23. Changchun High-tech Business Overview Table 24. Changchun High-tech Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 25. Changchun High-tech Similar Biological Medicinal Products Product Portfolio Table 26. Changchun High-tech Recent Development Table 27. Innovent Biologics Company Information Table 28. Innovent Biologics Business Overview Table 29. Innovent Biologics Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 30. Innovent Biologics Similar Biological Medicinal Products Product Portfolio Table 31. Innovent Biologics Recent Development Table 32. Saijin Biotechnology Company Information Table 33. Saijin Biotechnology Business Overview Table 34. Saijin Biotechnology Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 35. Saijin Biotechnology Similar Biological Medicinal Products Product Portfolio Table 36. Saijin Biotechnology Recent Development Table 37. Fuhong Hanlin Company Information Table 38. Fuhong Hanlin Business Overview Table 39. Fuhong Hanlin Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 40. Fuhong Hanlin Similar Biological Medicinal Products Product Portfolio Table 41. Fuhong Hanlin Recent Development Table 42. Baitai Biology Company Information Table 43. Baitai Biology Business Overview Table 44. Baitai Biology Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Baitai Biology Similar Biological Medicinal Products Product Portfolio Table 46. Baitai Biology Recent Development Table 47. Biotech Company Information Table 48. Biotech Business Overview Table 49. Biotech Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. Biotech Similar Biological Medicinal Products Product Portfolio Table 51. Biotech Recent Development Table 52. Sandoz Company Information Table 53. Sandoz Business Overview Table 54. Sandoz Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Sandoz Similar Biological Medicinal Products Product Portfolio Table 56. Sandoz Recent Development Table 57. Samsung Bioepies Co., Ltd Company Information Table 58. Samsung Bioepies Co., Ltd Business Overview Table 59. Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Product Portfolio Table 61. Samsung Bioepies Co., Ltd Recent Development Table 62. Amgen Company Information Table 63. Amgen Business Overview Table 64. Amgen Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Amgen Similar Biological Medicinal Products Product Portfolio Table 66. Amgen Recent Development Table 67. Celltrion Healthcare Company Information Table 68. Celltrion Healthcare Business Overview Table 69. Celltrion Healthcare Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Celltrion Healthcare Similar Biological Medicinal Products Product Portfolio Table 71. Celltrion Healthcare Recent Development Table 72. Coherus Biosciences, Inc. Company Information Table 73. Coherus Biosciences, Inc. Business Overview Table 74. Coherus Biosciences, Inc. Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Coherus Biosciences, Inc. Similar Biological Medicinal Products Product Portfolio Table 76. Coherus Biosciences, Inc. Recent Development Table 77. Eli Lilly Company Information Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Eli Lilly Similar Biological Medicinal Products Product Portfolio Table 81. Eli Lilly Recent Development Table 82. Novartis AG Company Information Table 83. Novartis AG Business Overview Table 84. Novartis AG Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Novartis AG Similar Biological Medicinal Products Product Portfolio Table 86. Novartis AG Recent Development Table 87. Pfizer Inc Company Information Table 88. Pfizer Inc Business Overview Table 89. Pfizer Inc Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Pfizer Inc Similar Biological Medicinal Products Product Portfolio Table 91. Pfizer Inc Recent Development Table 92. Stada Arzneimittel AG Company Information Table 93. Stada Arzneimittel AG Business Overview Table 94. Stada Arzneimittel AG Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Stada Arzneimittel AG Similar Biological Medicinal Products Product Portfolio Table 96. Stada Arzneimittel AG Recent Development Table 97. Teva Pharmaceutical Industries Ltd Company Information Table 98. Teva Pharmaceutical Industries Ltd Business Overview Table 99. Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Product Portfolio Table 101. Teva Pharmaceutical Industries Ltd Recent Development Table 102. Viatris Company Information Table 103. Viatris Business Overview Table 104. Viatris Similar Biological Medicinal Products Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Viatris Similar Biological Medicinal Products Product Portfolio Table 106. Viatris Recent Development Table 107. Global Similar Biological Medicinal Products Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 108. Global Similar Biological Medicinal Products Production by Region (2021-2026) & (Tons) Table 109. Global Similar Biological Medicinal Products Production Market Share by Region (2021-2026) Table 110. Global Similar Biological Medicinal Products Production Forecast by Region (2027-2032) & (Tons) Table 111. Global Similar Biological Medicinal Products Production Market Share Forecast by Region (2027-2032) Table 112. Global Similar Biological Medicinal Products Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Global Similar Biological Medicinal Products Production Value by Region (2021-2026) & (US$ Million) Table 114. Global Similar Biological Medicinal Products Production Value Market Share by Region (2021-2026) Table 115. Global Similar Biological Medicinal Products Production Value Forecast by Region (2027-2032) & (US$ Million) Table 116. Global Similar Biological Medicinal Products Market Average Price (US$/Ton) by Region (2021-2026) Table 117. Global Similar Biological Medicinal Products Market Average Price (US$/Ton) by Region (2027-2032) Table 118. Global Similar Biological Medicinal Products Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 119. Global Similar Biological Medicinal Products Consumption by Region (2021-2026) & (Tons) Table 120. Global Similar Biological Medicinal Products Consumption Market Share by Region (2021-2026) Table 121. Global Similar Biological Medicinal Products Forecasted Consumption by Region (2027-2032) & (Tons) Table 122. Global Similar Biological Medicinal Products Forecasted Consumption Market Share by Region (2027-2032) Table 123. North America Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 124. North America Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 125. North America Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 126. Europe Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 127. Europe Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 128. Europe Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 129. Asia Pacific Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 130. Asia Pacific Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 131. Asia Pacific Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 132. South America, Middle East & Africa Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 133. South America, Middle East & Africa Similar Biological Medicinal Products Consumption by Country (2021-2026) & (Tons) Table 134. South America, Middle East & Africa Similar Biological Medicinal Products Consumption by Country (2027-2032) & (Tons) Table 135. Global Similar Biological Medicinal Products Production by Type (2021-2026) & (Tons) Table 136. Global Similar Biological Medicinal Products Production by Type (2027-2032) & (Tons) Table 137. Global Similar Biological Medicinal Products Production Market Share by Type (2021-2026) Table 138. Global Similar Biological Medicinal Products Production Market Share by Type (2027-2032) Table 139. Global Similar Biological Medicinal Products Production Value by Type (2021-2026) & (US$ Million) Table 140. Global Similar Biological Medicinal Products Production Value by Type (2027-2032) & (US$ Million) Table 141. Global Similar Biological Medicinal Products Production Value Market Share by Type (2021-2026) Table 142. Global Similar Biological Medicinal Products Production Value Market Share by Type (2027-2032) Table 143. Global Similar Biological Medicinal Products Price by Type (2021-2026) & (US$/Ton) Table 144. Global Similar Biological Medicinal Products Price by Type (2027-2032) & (US$/Ton) Table 145. Global Similar Biological Medicinal Products Production by Application (2021-2026) & (Tons) Table 146. Global Similar Biological Medicinal Products Production by Application (2027-2032) & (Tons) Table 147. Global Similar Biological Medicinal Products Production Market Share by Application (2021-2026) Table 148. Global Similar Biological Medicinal Products Production Market Share by Application (2027-2032) Table 149. Global Similar Biological Medicinal Products Production Value by Application (2021-2026) & (US$ Million) Table 150. Global Similar Biological Medicinal Products Production Value by Application (2027-2032) & (US$ Million) Table 151. Global Similar Biological Medicinal Products Production Value Market Share by Application (2021-2026) Table 152. Global Similar Biological Medicinal Products Production Value Market Share by Application (2027-2032) Table 153. Global Similar Biological Medicinal Products Price by Application (2021-2026) & (US$/Ton) Table 154. Global Similar Biological Medicinal Products Price by Application (2027-2032) & (US$/Ton) Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Similar Biological Medicinal Products Distributors List Table 158. Similar Biological Medicinal Products Customers List Table 159. Similar Biological Medicinal Products Industry Trends Table 160. Similar Biological Medicinal Products Industry Drivers Table 161. Similar Biological Medicinal Products Industry Restraints Table 162. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Similar Biological Medicinal Products Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Monoclonal Antibodies Product Image Figure 7. Anti-inflammatory Drugs Product Image Figure 8. Immunomodulator Product Image Figure 9. Recombinant Hormone Product Image Figure 10. Others Product Image Figure 11. Oncology Product Image Figure 12. Blood Disorders Product Image Figure 13. Growth Hormone Deficiency Product Image Figure 14. Chronic and Autoimmune Diseases Product Image Figure 15. Others Product Image Figure 16. Global Similar Biological Medicinal Products Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Similar Biological Medicinal Products Production Value (2021-2032) & (US$ Million) Figure 18. Global Similar Biological Medicinal Products Production Capacity (2021-2032) & (Tons) Figure 19. Global Similar Biological Medicinal Products Production (2021-2032) & (Tons) Figure 20. Global Similar Biological Medicinal Products Average Price (US$/Ton) & (2021-2032) Figure 21. Global Similar Biological Medicinal Products Key Manufacturers, Manufacturing Sites & Headquarters Figure 22. Global Top 5 and 10 Similar Biological Medicinal Products Players Market Share by Production Value in 2025 Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global Similar Biological Medicinal Products Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 25. Global Similar Biological Medicinal Products Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 26. Global Similar Biological Medicinal Products Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 27. Global Similar Biological Medicinal Products Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. North America Similar Biological Medicinal Products Production Value (US$ Million) Growth Rate (2021-2032) Figure 29. Europe Similar Biological Medicinal Products Production Value (US$ Million) Growth Rate (2021-2032) Figure 30. China Similar Biological Medicinal Products Production Value (US$ Million) Growth Rate (2021-2032) Figure 31. Japan Similar Biological Medicinal Products Production Value (US$ Million) Growth Rate (2021-2032) Figure 32. Global Similar Biological Medicinal Products Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 33. Global Similar Biological Medicinal Products Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 35. North America Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 36. United States Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 37. United States Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. Canada Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. Mexico Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Europe Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Europe Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 42. Germany Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. France Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. U.K. Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Italy Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Russia Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Spain Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Netherlands Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Switzerland Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Sweden Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. Poland Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. Asia Pacific Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Asia Pacific Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 54. China Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Japan Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South Korea Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. India Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. Australia Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Taiwan Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Southeast Asia Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. South America, Middle East & Africa Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. South America, Middle East & Africa Similar Biological Medicinal Products Consumption Market Share by Country (2021-2032) Figure 63. Brazil Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. Argentina Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 65. Chile Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. Turkey Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 67. GCC Countries Similar Biological Medicinal Products Consumption and Growth Rate (2021-2032) & (Tons) Figure 68. Global Similar Biological Medicinal Products Production Market Share by Type (2021-2032) Figure 69. Global Similar Biological Medicinal Products Production Value Market Share by Type (2021-2032) Figure 70. Global Similar Biological Medicinal Products Price (US$/Ton) by Type (2021-2032) Figure 71. Global Similar Biological Medicinal Products Production Market Share by Application (2021-2032) Figure 72. Global Similar Biological Medicinal Products Production Value Market Share by Application (2021-2032) Figure 73. Global Similar Biological Medicinal Products Price (US$/Ton) by Application (2021-2032) Figure 74. Similar Biological Medicinal Products Value Chain Figure 75. Similar Biological Medicinal Products Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Similar Biological Medicinal Products Industry Opportunities and Challenges

Scope & coverage.

Types
  • Monoclonal Antibodies
  • Anti-inflammatory Drugs
  • Immunomodulator
  • Recombinant Hormone
  • Others
Applications
  • Oncology
  • Blood Disorders
  • Growth Hormone Deficiency
  • Chronic and Autoimmune Diseases
  • Others
Companies covered
  • CITIC Guojian
  • Changchun High-tech
  • Innovent Biologics
  • Saijin Biotechnology
  • Fuhong Hanlin
  • Baitai Biology
  • Biotech
  • Sandoz
  • Samsung Bioepies Co., Ltd
  • Amgen
  • Celltrion Healthcare
  • Coherus Biosciences, Inc.
  • Eli Lilly
  • Novartis AG
  • Pfizer Inc
  • Stada Arzneimittel AG
  • Teva Pharmaceutical Industries Ltd
  • Viatris

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Similar Biological Medicinal Products by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 Monoclonal Antibodies
  5. 2.2.3 Anti-inflammatory Drugs
  6. 2.2.4 Immunomodulator
  7. 2.2.5 Recombinant Hormone
  8. 2.2.6 Others
  9. 2.3 Similar Biological Medicinal Products by Application
  10. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  11. 2.3.2 Oncology
  12. 2.3.3 Blood Disorders
  13. 2.3.4 Growth Hormone Deficiency
  14. 2.3.5 Chronic and Autoimmune Diseases
  15. 2.3.6 Others
  16. 2.4 Global Market Growth Prospects
  17. 2.4.1 Global Similar Biological Medicinal Products Production Value Estimates and Forecasts (2021-2032)
  18. 2.4.2 Global Similar Biological Medicinal Products Production Capacity Estimates and Forecasts (2021-2032)
  19. 2.4.3 Global Similar Biological Medicinal Products Production Estimates and Forecasts (2021-2032)
  20. 2.4.4 Global Similar Biological Medicinal Products Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Similar Biological Medicinal Products Production by Manufacturers (2021-2026)
  2. 3.2 Global Similar Biological Medicinal Products Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Similar Biological Medicinal Products Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Similar Biological Medicinal Products Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Similar Biological Medicinal Products Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Similar Biological Medicinal Products Manufacturers, Product Type & Application
  7. 3.7 Global Similar Biological Medicinal Products Manufacturers Established Date
  8. 3.8 Global Similar Biological Medicinal Products Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CITIC Guojian
  2. 4.1.1 CITIC Guojian Similar Biological Medicinal Products Company Information
  3. 4.1.2 CITIC Guojian Similar Biological Medicinal Products Business Overview
  4. 4.1.3 CITIC Guojian Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 CITIC Guojian Product Portfolio
  6. 4.1.5 CITIC Guojian Recent Developments
  7. 4.2 Changchun High-tech
  8. 4.2.1 Changchun High-tech Similar Biological Medicinal Products Company Information
  9. 4.2.2 Changchun High-tech Similar Biological Medicinal Products Business Overview
  10. 4.2.3 Changchun High-tech Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Changchun High-tech Product Portfolio
  12. 4.2.5 Changchun High-tech Recent Developments
  13. 4.3 Innovent Biologics
  14. 4.3.1 Innovent Biologics Similar Biological Medicinal Products Company Information
  15. 4.3.2 Innovent Biologics Similar Biological Medicinal Products Business Overview
  16. 4.3.3 Innovent Biologics Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Innovent Biologics Product Portfolio
  18. 4.3.5 Innovent Biologics Recent Developments
  19. 4.4 Saijin Biotechnology
  20. 4.4.1 Saijin Biotechnology Similar Biological Medicinal Products Company Information
  21. 4.4.2 Saijin Biotechnology Similar Biological Medicinal Products Business Overview
  22. 4.4.3 Saijin Biotechnology Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Saijin Biotechnology Product Portfolio
  24. 4.4.5 Saijin Biotechnology Recent Developments
  25. 4.5 Fuhong Hanlin
  26. 4.5.1 Fuhong Hanlin Similar Biological Medicinal Products Company Information
  27. 4.5.2 Fuhong Hanlin Similar Biological Medicinal Products Business Overview
  28. 4.5.3 Fuhong Hanlin Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Fuhong Hanlin Product Portfolio
  30. 4.5.5 Fuhong Hanlin Recent Developments
  31. 4.6 Baitai Biology
  32. 4.6.1 Baitai Biology Similar Biological Medicinal Products Company Information
  33. 4.6.2 Baitai Biology Similar Biological Medicinal Products Business Overview
  34. 4.6.3 Baitai Biology Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Baitai Biology Product Portfolio
  36. 4.6.5 Baitai Biology Recent Developments
  37. 4.7 Biotech
  38. 4.7.1 Biotech Similar Biological Medicinal Products Company Information
  39. 4.7.2 Biotech Similar Biological Medicinal Products Business Overview
  40. 4.7.3 Biotech Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Biotech Product Portfolio
  42. 4.7.5 Biotech Recent Developments
  43. 4.8 Sandoz
  44. 4.8.1 Sandoz Similar Biological Medicinal Products Company Information
  45. 4.8.2 Sandoz Similar Biological Medicinal Products Business Overview
  46. 4.8.3 Sandoz Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Sandoz Product Portfolio
  48. 4.8.5 Sandoz Recent Developments
  49. 4.9 Samsung Bioepies Co., Ltd
  50. 4.9.1 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Company Information
  51. 4.9.2 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Business Overview
  52. 4.9.3 Samsung Bioepies Co., Ltd Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Samsung Bioepies Co., Ltd Product Portfolio
  54. 4.9.5 Samsung Bioepies Co., Ltd Recent Developments
  55. 4.10 Amgen
  56. 4.10.1 Amgen Similar Biological Medicinal Products Company Information
  57. 4.10.2 Amgen Similar Biological Medicinal Products Business Overview
  58. 4.10.3 Amgen Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Amgen Product Portfolio
  60. 4.10.5 Amgen Recent Developments
  61. 4.11 Celltrion Healthcare
  62. 4.11.1 Celltrion Healthcare Similar Biological Medicinal Products Company Information
  63. 4.11.2 Celltrion Healthcare Similar Biological Medicinal Products Business Overview
  64. 4.11.3 Celltrion Healthcare Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Celltrion Healthcare Product Portfolio
  66. 4.11.5 Celltrion Healthcare Recent Developments
  67. 4.12 Coherus Biosciences, Inc.
  68. 4.12.1 Coherus Biosciences, Inc. Similar Biological Medicinal Products Company Information
  69. 4.12.2 Coherus Biosciences, Inc. Similar Biological Medicinal Products Business Overview
  70. 4.12.3 Coherus Biosciences, Inc. Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Coherus Biosciences, Inc. Product Portfolio
  72. 4.12.5 Coherus Biosciences, Inc. Recent Developments
  73. 4.13 Eli Lilly
  74. 4.13.1 Eli Lilly Similar Biological Medicinal Products Company Information
  75. 4.13.2 Eli Lilly Similar Biological Medicinal Products Business Overview
  76. 4.13.3 Eli Lilly Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 Eli Lilly Product Portfolio
  78. 4.13.5 Eli Lilly Recent Developments
  79. 4.14 Novartis AG
  80. 4.14.1 Novartis AG Similar Biological Medicinal Products Company Information
  81. 4.14.2 Novartis AG Similar Biological Medicinal Products Business Overview
  82. 4.14.3 Novartis AG Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  83. 4.14.4 Novartis AG Product Portfolio
  84. 4.14.5 Novartis AG Recent Developments
  85. 4.15 Pfizer Inc
  86. 4.15.1 Pfizer Inc Similar Biological Medicinal Products Company Information
  87. 4.15.2 Pfizer Inc Similar Biological Medicinal Products Business Overview
  88. 4.15.3 Pfizer Inc Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  89. 4.15.4 Pfizer Inc Product Portfolio
  90. 4.15.5 Pfizer Inc Recent Developments
  91. 4.16 Stada Arzneimittel AG
  92. 4.16.1 Stada Arzneimittel AG Similar Biological Medicinal Products Company Information
  93. 4.16.2 Stada Arzneimittel AG Similar Biological Medicinal Products Business Overview
  94. 4.16.3 Stada Arzneimittel AG Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  95. 4.16.4 Stada Arzneimittel AG Product Portfolio
  96. 4.16.5 Stada Arzneimittel AG Recent Developments
  97. 4.17 Teva Pharmaceutical Industries Ltd
  98. 4.17.1 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Company Information
  99. 4.17.2 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Business Overview
  100. 4.17.3 Teva Pharmaceutical Industries Ltd Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  101. 4.17.4 Teva Pharmaceutical Industries Ltd Product Portfolio
  102. 4.17.5 Teva Pharmaceutical Industries Ltd Recent Developments
  103. 4.18 Viatris
  104. 4.18.1 Viatris Similar Biological Medicinal Products Company Information
  105. 4.18.2 Viatris Similar Biological Medicinal Products Business Overview
  106. 4.18.3 Viatris Similar Biological Medicinal Products Production Capacity, Value and Gross Margin (2021-2026)
  107. 4.18.4 Viatris Product Portfolio
  108. 4.18.5 Viatris Recent Developments
5 Global Similar Biological Medicinal Products Production by Region
  1. 5.1 Global Similar Biological Medicinal Products Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Similar Biological Medicinal Products Production by Region: 2021-2032
  3. 5.2.1 Global Similar Biological Medicinal Products Production by Region: 2021-2026
  4. 5.2.2 Global Similar Biological Medicinal Products Production Forecast by Region (2027-2032)
  5. 5.3 Global Similar Biological Medicinal Products Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Similar Biological Medicinal Products Production Value by Region: 2021-2032
  7. 5.4.1 Global Similar Biological Medicinal Products Production Value by Region: 2021-2026
  8. 5.4.2 Global Similar Biological Medicinal Products Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Similar Biological Medicinal Products Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Similar Biological Medicinal Products Production and Value, YOY Growth
  11. 5.6.1 North America Similar Biological Medicinal Products Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Similar Biological Medicinal Products Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Similar Biological Medicinal Products Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Similar Biological Medicinal Products Production Value Estimates and Forecasts (2021-2032)
6 Global Similar Biological Medicinal Products Consumption by Region
  1. 6.1 Global Similar Biological Medicinal Products Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Similar Biological Medicinal Products Consumption by Region (2021-2032)
  3. 6.2.1 Global Similar Biological Medicinal Products Consumption by Region: 2021-2026
  4. 6.2.2 Global Similar Biological Medicinal Products Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Similar Biological Medicinal Products Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Similar Biological Medicinal Products Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Similar Biological Medicinal Products Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Similar Biological Medicinal Products Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Similar Biological Medicinal Products Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Similar Biological Medicinal Products Production by Type (2021-2032)
  2. 7.1.1 Global Similar Biological Medicinal Products Production by Type (2021-2032) & (Tons)
  3. 7.1.2 Global Similar Biological Medicinal Products Production Market Share by Type (2021-2032)
  4. 7.2 Global Similar Biological Medicinal Products Production Value by Type (2021-2032)
  5. 7.2.1 Global Similar Biological Medicinal Products Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Similar Biological Medicinal Products Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Similar Biological Medicinal Products Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Similar Biological Medicinal Products Production by Application (2021-2032)
  2. 8.1.1 Global Similar Biological Medicinal Products Production by Application (2021-2032) & (Tons)
  3. 8.1.2 Global Similar Biological Medicinal Products Production Market Share by Application (2021-2032)
  4. 8.2 Global Similar Biological Medicinal Products Production Value by Application (2021-2032)
  5. 8.2.1 Global Similar Biological Medicinal Products Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Similar Biological Medicinal Products Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Similar Biological Medicinal Products Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Similar Biological Medicinal Products Value Chain Analysis
  2. 9.1.1 Similar Biological Medicinal Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Similar Biological Medicinal Products Production Mode & Process
  5. 9.2 Similar Biological Medicinal Products Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Similar Biological Medicinal Products Distributors
  8. 9.2.3 Similar Biological Medicinal Products Customers
10 Global Similar Biological Medicinal Products Analyzing Market Dynamics
  1. 10.1 Similar Biological Medicinal Products Industry Trends
  2. 10.2 Similar Biological Medicinal Products Industry Drivers
  3. 10.3 Similar Biological Medicinal Products Industry Opportunities and Challenges
  4. 10.4 Similar Biological Medicinal Products Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research